Synthetic Microchromosome vector delivery systems
Latest Information Update: 20 Mar 2007
At a glance
- Originator Athersys
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Unspecified
Most Recent Events
- 20 Mar 2007 Discontinued - Preclinical for Undefined in USA (Parenteral)
- 02 Jul 2002 This technology is still in active development
- 12 Apr 2000 Preclinical development for Undefined in USA (Parenteral)